Advertisement
Advertisement

COCP

COCP logo

Cocrystal Pharma, Inc. Common Stock

0.99
USD
Sponsored
-0.01
-0.50%
Jan 30, 15:43 UTC -5
Closed
exchange

After-Market

1.00

+0.01
+0.50%

COCP Earnings Reports

Positive Surprise Ratio

COCP beat 23 of 29 last estimates.

79%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.17
Implied change from Q3 25 (Revenue/ EPS)
--
/
-10.53%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-46.88%

Cocrystal Pharma, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, COCP reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 11.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.17 USD, with revenue projected to reach -- USD, implying an decrease of -10.53% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Cocrystal Pharma, Inc. Common Stock reported EPS of -$0.19, beating estimates by 11.3%, and revenue of $0.00, 0% as expectations.
The stock price moved -- 0%, changed from $1.03 before the earnings release to $1.03 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 5 analysts, Cocrystal Pharma, Inc. Common Stock is expected to report EPS of -$0.17 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement